Active	Status	Sponsor type	Region	Phase	Filter
4 Active 0 Inactive 4 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Butcher, Ken
LASER, NCT03494530 / 2008-006161-84: Lixiana Acute Stroke Evaluation Registry	Completed	4	70	Canada	Edoxaban 60 MG, Lixiana, Edoxaban 30 mg	University of Alberta	Ischemic Stroke, Atrial Fibrillation, Hemorrhagic Transformation Stroke	12/21	12/21
ETERNAL-LVO, NCT04454788: Extending the Time Window for Tenecteplase by Effective Reperfusion in Patients with Large Vessel Occlusion	Terminated	3	242	RoW	Tenecteplase, Standard Care (which may include intravenous Alteplase)	University of Melbourne, Professor Mark Parsons	Ischemic Stroke	07/24	01/25
STARS, NCT05363397: Safety and Tolerability of Adjunctive TBO-309 in Reperfusion for Stroke	Suspended	2	80	RoW	TBO-309	The George Institute, Heart Research Institute	Acute Ischemic Stroke	02/26	05/26
EVACUATE, NCT04434807: Ultra-Early, Minimally inVAsive intraCerebral Haemorrhage evacUATion Versus Standard trEatment	Recruiting	N/A	240	RoW	Minimally invasive hematoma evacuation	University of Melbourne	Intra Cerebral Hemorrhage, Stroke	12/25	12/26